Publication | Closed Access

Fludarabine and busulfan as a myeloablative conditioning regimen for allogeneic stem cell transplantation in high- and standard-risk leukemic patients

Hematological MalignancyStandard-risk Leukemic PatientsCell TherapyTransplantationMarrow TransplantationOncologyStem Cell TransplantationImmunologyHematologyMyeloablative Conditioning RegimenBlood TransplantationMedicineCell Transplantation